CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 2,588,794 shares at $1.20 ($3,106,553)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 131,800 shares at an average $2.93 ($385,769)
- 4 Open-market buy 10% owner bought 947 shares at $4.34 ($4,114)
- 4 Open-market buy Director bought 5,000 shares at $5.29 ($26,450)
- 4 Open-market buy Director bought 10,000 shares at an average $5.61 ($56,100)
- 4 Open-market sale See Remarks sold 164,686 shares at $5.78 ($952,116)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 2 of 6 · 119 filings